Gland Pharma Limited
GLAND
Hisse Senetlerindeki Sıralama
#3424
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Hisse Fiyatı
$30.19
Piyasa Değeri
$4.98B
Değişim (1 gün)
-6.61%
Değişim (1 yıl)
38.21%
Ülke
IN
Ticaret Gland Pharma Limited (GLAND)
Kategori
Healthcare
Gland Pharma Limited (GLAND) için P/B oranı
October 2026 itibarıyla P/B oranı TTM: 4.54
Gland Pharma Limited şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 4.54'dir. 2025 yılının sonunda şirketin P/B oranı 2.80 idi.
Gland Pharma Limited için P/B oranı geçmişi 2017 - 2026 arası
Her yılın sonunda P/B oranı
| Yıl | P/B Oranı | Değiştir |
|---|---|---|
| 2026 (TTM) | 4.54 | 61.99% |
| 2025 | 2.80 | -18.34% |
| 2024 | 3.43 | 30.52% |
| 2023 | 2.62 | -65.12% |
| 2022 | 7.52 | 13.22% |
| 2021 | 6.64 | -14.07% |
| 2020 | 7.73 | -21.51% |
| 2019 | 9.85 | -15.78% |
| 2018 | 11.70 | -13.30% |
| 2017 | 13.49 | 0.00% |
Benzer şirketler veya rakipler için P/B oranı
| Şirket | P/B Oranı | P/B Oranı Farkı | Ülke |
|---|---|---|---|
| 1.9834 | -56.27% |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | -71.07% |
JP
|
|
| 6.3468 | 39.93% |
CH
|
|
| 5.041 | 11.14% |
IN
|
